表 1.
研究对象的一般资料
General information of study subjects
| Characteristics | Ua≤420 μmol/L | Ua>420 μmol/L | t or χ2 | P |
| BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; HbA1c: Glycosylated hemoglobin; FPG: Fasting plasma glucose; FINS: Fasting insulin; HOMA2-IR: HOMA2 insulin resistance; FCP: Fasting C-peptide; HOMA2 IR-CP: C-peptide-based HOMA2 insulin resistance; TC: Total cholesterol; TG: Triglyceride; LDL-c: Low density lipoprotein cholesterol; HDL-c: High density lipoprotein cholesterol; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; eGFR: Estimated glomerular filtration rate. 1 mmHg=0.133 kPa. | ||||
| n | 37242 | 8775 | - | - |
| Gender (female) | 15637 (42.0%) | 290 (3.3%) | 4693.419 | <0.001 |
| Age (year) | 50.45±9.98 | 48.20±9.58 | -19.170 | <0.001 |
| BMI (kg/m2) | 24.62±3.38 | 26.94±3.24 | 55.227 | <0.001 |
| SBP (mmHg) | 120.85±18.87 | 127.13±17.44 | 26.936 | <0.001 |
| DBP (mmHg) | 80.74±11.85 | 85.45±11.57 | 31.846 | <0.001 |
| HbA1c (%) | 5.79±0.79 | 5.79±0.67 | -0.295 | 0.768 |
| FPG (mmol/L) | 5.58±1.32 | 5.74±1.13 | 10.680 | <0.001 |
| FINS (μU/mL) | 8.65 (5.99, 12.46) | 11.89 (8.40, 16.68) | 43.577 | <0.001 |
| HOMA2-IR | 1.32 (0.91, 1.91) | 1.82 (1.29, 2.54) | 40.888 | <0.001 |
| FCP (ng/mL) | 2.22 (1.75, 2.83) | 2.97 (2.40, 3.67) | 69.940 | <0.001 |
| HOMA2 IR-CP | 1.67 (1.29, 2.16) | 2.26 (1.81, 2.82) | 65.380 | <0.001 |
| TC (mmol/L) | 4.71±0.94 | 4.85±0.98 | 12.251 | <0.001 |
| TG (mmol/L) | 1.65±1.45 | 2.56±1.95 | 49.250 | <0.001 |
| LDL-c (mmol/L) | 3.15±0.88 | 3.19±0.90 | 4.364 | <0.001 |
| HDL-c (mmol/L) | 1.31±0.37 | 1.11±0.29 | -47.005 | <0.001 |
| ALT (U/L) | 17.80 (13.00, 25.70) | 25.20 (18.20, 36.80) | 37.662 | <0.001 |
| AST (U/L) | 17.40 (14.70, 21.20) | 20.00 (16.70, 25.10) | 25.387 | <0.001 |
| eGFR (mL/min/m2) | 105.89±14.89 | 103.39±18.30 | -13.519 | <0.001 |